Sorrento Therapeutics (SRNE) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free SRNE Stock Alerts $0.01 -0.01 (-42.19%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSorrento Therapeutics Inc SRNEmorningstar.com - April 26 at 6:22 AMSorrento Therapeutics (NASDAQ:SRNE) Now Covered by StockNews.comamericanbankingnews.com - April 21 at 2:14 AMJudge Declines to Dismiss Sorrento Therapeutics Bankruptcy Casewsj.com - March 12 at 6:20 PMVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.tmcnet.com - February 27 at 9:57 AMVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.businesswire.com - February 27 at 7:30 AMSorrento Therapeutics (NASDAQ:SRNE) Stock Price Passes Below 200 Day Moving Average of $0.11marketbeat.com - February 9 at 4:17 AMSorrento Therapeutics, Inc. (0L85.L)finance.yahoo.com - January 9 at 10:46 AMSorrento Therapeutics Inc SRNEQmorningstar.com - November 5 at 10:27 AMSorrento, Italy - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - October 14 at 3:34 PMCourt rules Virpax CEO Anthony Mack breached his agreement with Sorrento Therapeuticsbizjournals.com - September 7 at 5:29 PMSorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bidfinance.yahoo.com - August 8 at 11:08 AMWildcat Claims CNSL Shareholders Are Being Ripped Off in Weak Deal, Claiming $14 Price is Requiredmsn.com - July 13 at 12:58 PMSorrento sees promising phase 2 results for abivertinib for lymphomaseekingalpha.com - July 5 at 1:04 PMSRNEQ Sorrento Therapeutics, Inc.seekingalpha.com - June 22 at 12:10 PMSorrento Therapeutics (OTC: SRNE.Q)fool.com - June 14 at 7:57 PMUBS Group AG Has $2.12 Million Stock Position in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)marketbeat.com - June 6 at 4:40 AMSorrento Therapeutics, Inc. (SRNEQ)finance.yahoo.com - April 24 at 8:31 PMSorrento Therapeutics Opponent Loses Chapter 11 Committee Seatwsj.com - March 21 at 1:54 AMFirm Retention Summary: Sorrento Therapeutics Inc.wsj.com - March 18 at 10:26 AMWhy Sorrento Therapeutics (SRNE) Stock Plummeted Todaythestreet.com - March 15 at 3:13 AMSorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Credit Suisse AGmarketbeat.com - March 8 at 4:24 AMIs a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?finance.yahoo.com - March 2 at 2:06 PMScilex Holding Company announces the commercial launch of ELYXYBTM (celecoxib oral solution) in the U.S., strengthening its leadership position in non-opioid pain managementfinance.yahoo.com - February 27 at 5:53 PMWhy Sorrento Therapeutics Stock Is Soaring Todaybenzinga.com - February 22 at 6:42 PMBankrupt Sorrento Therapeutics Secures Court Approval for $75M Financingyahoo.com - February 22 at 6:42 PMSorrento Therapeutics surges 28% as court nods for a $75M loanseekingalpha.com - February 22 at 3:07 AMSorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Casefinance.yahoo.com - February 21 at 10:06 PMSorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)finance.yahoo.com - February 18 at 9:14 PMThinking about buying stock in Esports Entertainment, Marathon Digital, Sorrento Therapeutics, Nu Holdings, or ContextLogic?benzinga.com - February 17 at 12:49 PMWhy Kim Jong Un’s Daughter Is All Over North Korean Mediafinance.yahoo.com - February 15 at 8:01 AMSorrento Therapeutics (SRNE) Loses -77.24% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerfinance.yahoo.com - February 14 at 3:25 PMSorrento Therapeutics Files For Bankruptcyuk.finance.yahoo.com - February 14 at 5:24 AMHot Stocks: TDC climbs on earnings; FSLY upgrade; TWLO restructuring; SRNE bankruptcyseekingalpha.com - February 13 at 5:40 PMSorrento Therapeutics Files for Bankruptcy to Halt $173 Million Licensing Judgmentswsj.com - February 13 at 5:40 PMSorrento Therapeutics stock plummets more than 60% on news of bankruptcy filingproactiveinvestors.com - February 13 at 5:40 PMSorrento Therapeutics Stock Is Sinking: What's Going On?markets.businessinsider.com - February 13 at 5:40 PMSorrento Therapeutics Stock Nosedives After Filing Bankruptcy Paperworkfinance.yahoo.com - February 13 at 5:40 PMJoint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.finance.yahoo.com - February 13 at 5:40 PMThinking about buying stock in Sorrento Therapeutics, Bed Bath & Beyond, C3.ai, Expion360, or SoundHound AI?benzinga.com - February 13 at 12:40 PMSorrento sheds 60% after bankruptcy filing (update)msn.com - February 13 at 12:40 PMA Sorrento Therapeutics, Inc. (NASDAQ:SRNE) insider increased their holdings by 2.0% last yearfinance.yahoo.com - February 13 at 7:36 AMScilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., acquires rights to FDA-Approved ELYXYB™ in the U.S. and Canada for the acute treatment of migrainefinance.yahoo.com - February 12 at 8:09 PMSorrento Therapeutics, Inc. (NASDAQ:SRNE) Shares Bought by Victory Capital Management Inc.marketbeat.com - February 10 at 4:14 AMSG Americas Securities LLC Has $84,000 Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)marketbeat.com - February 9 at 4:04 AM5 Hot Healthcare Stocks to Buy Nowinsidermonkey.com - February 3 at 1:43 PMRaymond James & Associates Increases Stock Holdings in Sorrento Therapeutics, Inc. (NASDAQ:SRNE)marketbeat.com - February 3 at 4:11 AMSorrento Issues Supplement to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stockwsj.com - February 3 at 3:47 AMSorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stockfinance.yahoo.com - February 2 at 5:44 PMBarclays PLC Purchases 1,829,031 Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)marketbeat.com - February 1 at 4:54 AMAnalysts Are Bullish on These Healthcare Stocks: Sorrento Therapeutics (SRNE), Aethlon Medical (AEMD)markets.businessinsider.com - January 31 at 7:44 AM Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you. 4 simple steps to protect your privacy and money before it’s too late. SRNE Media Mentions By Week SRNE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRNE News Sentiment▼0.000.32▲Average Medical News Sentiment SRNE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRNE Articles This Week▼20▲SRNE Articles Average Week Get Sorrento Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Coeptis Therapeutics News Today Senti Biosciences News Today Genetic Technologies News Today Inhibikase Therapeutics News Today Organovo News Today BioCardia News Today Creative Medical Technology News Today Surrozen News Today Titan Pharmaceuticals News Today Aptose Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRNE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
